文献速递细菌感染、耐药与抗菌药物医院感染防控

巴基斯坦社区卫健康工作者治疗2-59月龄儿童快速呼吸性肺炎:3天阿莫西林与5天复方磺胺甲噁唑的整群随机试验比较

Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
PubMed 文献 · Clin Infect Dis · 2019-01-01

在巴基斯坦Haripur区开展的整群随机等效性试验中,2-59月龄快速呼吸性肺炎患儿经社区卫健康工作者治疗,3天口服阿莫西林组治疗失败率3.6%,5天复方磺胺甲噁唑组为9.1%,校正整群效应后风险差为-5.5%(95%CI -7.4至-3.7%),无死亡或严重不良事件。

要点

  • 3天阿莫西林治疗失败风险低于5天复方磺胺甲噁唑,风险差-5.5%(95%CI -7.4至-3.7%)。
  • 不完整服药者治疗失败风险略增,风险差2.9%(95%CI 1.6-4.1%)。
  • 研究中无死亡或严重不良事件发生。

核心结论

  • 由社区卫健康工作者给予的3天口服阿莫西林是2-59月龄儿童快速呼吸性肺炎有效且安全的治疗。
  • 较短疗程的阿莫西林可提高治疗依从性、成本低并减轻抗菌药物耐药压力。

研究设计与样本

  • 在巴基斯坦Haripur区开展的非盲、整群随机、对照等效性试验。
  • 14个干预整群给予口服阿莫西林混悬液50 mg/kg/天共3天,14个对照整群给予口服复方磺胺甲噁唑混悬液(甲氧苄啶8 mg/kg和磺胺甲噁唑40 mg/kg/天)共5天,由社区卫健康工作者实施。
  • 主要结局为干预整群第4天、对照整群第6天的治疗失败。

主要发现

  • 干预整群治疗失败率为3.6%(326例),对照整群为9.1%(592例)。
  • 校正整群效应后,干预整群治疗失败风险低于对照整群,风险差-5.5%(95%CI -7.4至-3.7%)。
  • 不完整服药者较完整服药者治疗失败风险略增,风险差2.9%(95%CI 1.6-4.1%)。
  • 未发生死亡或严重不良事件。

临床怎么用

  • 在社区层面可由卫健康工作者使用3天口服阿莫西林方案治疗2-59月龄快速呼吸性肺炎患儿。
  • 短疗程阿莫西林可能有助于提高依从性并减少抗菌药物耐药压力。

局限性

  • 试验为非盲设计。
  • 分析为符合方案分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Globally, most deaths due to childhood pneumonia occur at the community level. Some countries are still using oral co-trimoxazole, despite a World Health Organization recommendation of oral amoxicillin for the treatment of fast-breathing pneumonia in children at the community level. METHODS: We conducted an unblinded, cluster-randomized, controlled-equivalency trial in Haripur District, Pakistan. Children 2-59 months of age with fast-breathing pneumonia were treated with oral amoxicillin suspension (50 mg/kg/day) for 3 days in 14 intervention clusters and oral co-trimoxazole suspension (8 mg trimethoprim/kg and 40 mg sulfamethoxazole/kg/day) for 5 days in 14 control clusters by lady health workers (LHW). The primary outcome was treatment failure by day 4 for intervention clusters and by day 6 for control clusters. The analysis was per protocol. RESULTS: Out of the 15 749 cases enrolled in the study, 9153 cases in intervention and 6509 cases in control clusters were included in the analysis. Treatment failure rates were 3.6% (326) in intervention clusters and 9.1% (592) in control clusters. After adjusting for clustering, the risk of treatment failure was lower in intervention clusters (risk difference [RD] -5.5%, 95% confidence interval [CI] -7.4--3.7%) than in control clusters. Children with incomplete adherence had a small increase in treatment failure versus those with complete adherence (RD 2.9%, 95% CI 1.6-4.1%). No deaths or serious adverse events occurred. CONCLUSIONS: A 3-day course of oral amoxicillin, administered by LHWs, is an effective and safe treatment for fast-breathing pneumonia in children 2-59 months of age. A shorter course of amoxicillin improves adherence to therapy, is low in cost, and puts less pressure on antimicrobial resistance. CLINICAL TRIALS REGISTRATION: ISRCTN10618300.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sadruddin S, Khan IUH, Fox MP, et al. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial. Clin Infect Dis. 2019. PMID: 30596964. doi:10.1093/cid/ciy918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。